Our Pharma Insights Blog
Drug development is primarily driven by three factors: quality, efficacy, and safety. The essential quality,…
To identify potential safety concerns such as unpleasant adverse effects of the medicines, ICH provides…
The mainstay of drug development is based on 3 parameters such as quality, efficacy and…
The People’s Republic of China is a huge pharmaceutical market and big pharma companies have…
A global initiative called the International Council for Harmonization of Technical Requirements for Pharmaceuticals for…
Generic drugs are copies of the original branded drugs that are made available in the…
The manufacturing of pharmaceutical products by a third party is referred to as third-party pharmaceutical…
The centre for drug evaluation and research (CDER) is responsible for ensuring availability of safe…
The development of drugs is a long process, and it takes 12-15 years to complete…
Conducting clinical trials is a multifaceted activity involving several stakeholders and participants. Once the trial…
The European Union has established a centralised regulatory authority responsible for authorising new medicines within…
The term “quality assurance” (QA) refers to a wide notion that encompasses all the critical…